Rituximab is a monoclonal anti-CD20 antibody used to treat non-Hodgkin's lymphoma, chronic lymphocytic leukemia, Wegener's granulomatosis, pemphigus vulgaris, and rheumatoid arthritis.
Rituximab(Rituximab)How to use?
Rituximab is given as an intravenous infusion where your doctor injects the drug. Do not give by intravenous push or bolus injection. Rituximab should be carefully observed as adverse reactions may be fatal if they occur. The dose for adultsBcell non-Hodgkin lymphoma is 375mg/m²2 . Chronic Lymphocytic Leukemia(CLL)The dose is 375mg/m22 in the first cycle and 500mg/cubic meter2administered in combination with FC every 28 days in cycles 2-6. The dose of rituximab in combination with methotrexate is intravenous infusion 2-1, 000 every 24 weeks or 2 weeks apart according to clinical evaluation. mg (one course of treatment), but not earlier than every 16 weeks. It is recommended that intravenous administration of methylprednisolone 100 mg or equivalent glucocorticoid 30 minutes before each infusion. In adults with active GPA and MPA the induction dose of combined glucocorticoids is 375 mg/m2 once weekly for 4 weeks. Suffering fromGPAAdult patients with and MPA achieved disease control with induction therapy and a combination of glucocorticoids, with follow-up doses of 500 mgintravenous infusions two weeks apart, followed by 500 mg intravenous infusions every 6months based on clinical assessment. If you want to get more high-quality information, you can contact YaoDe. YaoDe will do its best to learn more about high-quality overseas drugs for you.
.jpeg)
